Pilot Projects Program

试点项目计划

基本信息

  • 批准号:
    10252027
  • 负责人:
  • 金额:
    $ 57.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-02 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

There is an urgent need to increase diversity in research in order to improve health care for underserved groups. Hispanics, women and unrepresented minorities (URM) early stage and new investigators are at a disadvantage in obtaining funding from the National Institutes of Health. The Pilot Project Program (PPP) Core of the Hispanic Alliance for Clinical and Translational Research (Alliance) is a critical component to this Institutional Development Award in Clinical and Translational Research (IDeA-CTR) application. The long- term goal of the PPP is to increase the number of URM scientists in clinical and translational research dedicated to the study of health conditions affecting a Hispanic population. The objective of the PPP is to increase the cadre of URM independent investigators in clinical and translational research addressing health conditions prevalently affecting the medically underserved Hispanic population Puerto of Rico with an emphasis on community engagement. This will be accomplished through sustained collaboration and coordination of clinical and translational research activities as proposed in the following aims: 1) advance the development of innovative and interdisciplinary collaborative clinical and translational research on health conditions affecting the Hispanic population through the support of junior faculty (early stage and new investigators) and established investigators via pilot projects; 2) promote community engagement translational research pilot projects for the studies of community health; and 3) foster the development of competitive researchers in clinical and translational research by designing in collaboration with the Professional Development Core (PDC) a tailor-made career development plan for providing the needed skills and preliminary data. Reflecting on the accomplishments of the current PPP, the activities of the Alliance's PPP build on our success's while seeking to address those challenges identified. As a result, the PPP will: 1. Fund 6 pilot projects per year and with adequate justification expand funding up to 2 years; 2. Coordinate Pilot monitoring with other Alliance cores (e.g., PDC, Community Engagement and Outreach Core [CoE], Biostatistics, Epidemiology and Research Design, and Tracking and Evaluation Core) to assure compliance with the requirements of publications and grant submission; 3. Conduct mock study sessions where the investigator can be a silent observant of the review process; 4. Participate in the Alliance's Annual Scientific Meeting where a productivity award will be given to Pilot Project awardees; 5. Schedule meetings with mentors to discuss mentoring styles and problems mentors/mentees may be experiencing; 6. Collaborate with CoE in disseminating scientific information to the community in the activity titled “Town Hall Meeting with a Scientist: Science & Health” and 7. Establish an interdisciplinary and interinstitutional working group to assure diversity in the investigators, collaborations, and research topics supported. The Alliance PPP Core will increase the cadre of URM independent investigators and will foster further research on health conditions of the Hispanic population leading to improved wellbeing.
迫切需要增加研究的多样性,以改善服务不足群体的卫生保健。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VALERIE WOJNA其他文献

VALERIE WOJNA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VALERIE WOJNA', 18)}}的其他基金

Astrocyte-derived exosomes contribute to HIV neuropathogenesis.
星形胶质细胞衍生的外泌体有助于 HIV 神经发病。
  • 批准号:
    10534936
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
Astrocyte-derived exosomes contribute to HIV neuropathogenesis.
星形胶质细胞衍生的外泌体有助于 HIV 神经发病。
  • 批准号:
    10652615
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10417257
  • 财政年份:
    2020
  • 资助金额:
    $ 57.15万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10654615
  • 财政年份:
    2020
  • 资助金额:
    $ 57.15万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10027572
  • 财政年份:
    2020
  • 资助金额:
    $ 57.15万
  • 项目类别:
Soluble Insulin Receptor Dysfunction Correlates with HAND in HIV+ women on CART
可溶性胰岛素受体功能障碍与接受 CART 治疗的 HIV 女性中的 HAND 相关
  • 批准号:
    8294543
  • 财政年份:
    2011
  • 资助金额:
    $ 57.15万
  • 项目类别:
Soluble Insulin Receptor Dysfunction Correlates with HAND in HIV+ women on CART
可溶性胰岛素受体功能障碍与接受 CART 治疗的 HIV 女性中的 HAND 相关
  • 批准号:
    8208259
  • 财政年份:
    2011
  • 资助金额:
    $ 57.15万
  • 项目类别:
PATHOPHYSIOLOGY OF HIV IN WOMEN
女性艾滋病毒的病理生理学
  • 批准号:
    7381024
  • 财政年份:
    2006
  • 资助金额:
    $ 57.15万
  • 项目类别:
PATHOPHYSIOLOGY OF HIV IN WOMEN
女性艾滋病毒的病理生理学
  • 批准号:
    7169091
  • 财政年份:
    2005
  • 资助金额:
    $ 57.15万
  • 项目类别:
MRS AND HIV DEMENTIA IN PUERTO RICAN WOMEN
波多黎各妇女中的夫人和艾滋病毒痴呆症
  • 批准号:
    7169087
  • 财政年份:
    2005
  • 资助金额:
    $ 57.15万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 57.15万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 57.15万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 57.15万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 57.15万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 57.15万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 57.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了